Orchestra BioMed Holdings, Inc. Payments of Stock Issuance Costs
Orchestra BioMed Holdings, Inc. (OBIO) reported Payments of Stock Issuance Costs of $9.42 million for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2023-01-25
- Orchestra BioMed Holdings, Inc. payments of stock issuance costs for the quarter ending 2022-03-31 was $9.42M.
- Orchestra BioMed Holdings, Inc. payments of stock issuance costs for the quarter ending 2021-12-31 was $0.00.
- Orchestra BioMed Holdings, Inc. payments of stock issuance costs for fiscal 2021 was $9.42M.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 4 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 7 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|---|---|
| 2022-03-31 | $9.42M 10-Q · filed 2022-05-13 | $9.42M derived: sum of 2 quarters · filed 2023-01-25 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-01-25 | $9.42M 10-K · filed 2023-01-25 | ||||
| 2021-09-30 | $9.42M 10-Q/A · filed 2022-03-31 | |||||
| 2020-12-31 | $3.74M 10-K/A · filed 2022-03-31 | |||||
| 2020-09-30 | $3.74M 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |